Cetera Investment Advisers
PALI icon

Cetera Investment Advisers’s Palisade Bio PALI Stock Holding History

Cetera Investment Advisers’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4K Sell
10,506
-6
-0.1% -$11 ﹤0.01% 4663
2025
Q4 		$24.7K Buy
+10,512
New +$20.2K ﹤0.01% 4565
2025
Q1 		– Sell
-70,006
Closed -$116K – 4046
2024
Q4 		$116K Buy
+70,006
New +$184K ﹤0.01% 3548

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Cetera Investment Advisers's PALI Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Palisade Bio (PALI) stake by 0.06% in Q1 2026, selling an estimated $11 and leaving 10,506 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4663.

Cetera Investment Advisers first reported a position in PALI in Q4 2024 and has held it in 3 quarters since. The position peaked at $116K in Q4 2024. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Cetera Investment Advisers held 10,506 shares of Palisade Bio worth $18.4K as of Q1 2026.
  • Cetera Investment Advisers sold 6 Palisade Bio shares in Q1 2026, an estimated $11.
  • Palisade Bio made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4663 holding.
  • Cetera Investment Advisers first reported a position in Palisade Bio in Q4 2024 and has held it in 3 quarters since.
  • Cetera Investment Advisers's Palisade Bio position peaked at $116K in Q4 2024.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.